Exploring staphylococcus in urinary tract infections: A systematic review and meta-analysis on the epidemiology, antibiotic resistance and biofilm formation.

This study aimed to determine the epidemiology, biofilm formation and antibiotic resistance of staphylococci collected worldwide in the context of UTIs. This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Forty studies from 23 countries were selected for quantitative review. Electronic databases (PubMed, Scopus, Google Scholar, and Web of Sciences) were searched for articles published between 2010 and 2024 on the epidemiology, biofilm formation, and antibiotic resistance of uropathogenic staphylococci. Strict inclusion and exclusion standards were applied during the review of the articles. Forty articles were included in this systematic review. The prevalence of uropathogenic staphylococci varies from country to country, with the pooled prevalence of S. aureus and coagulase-negative staphylococci (CoNS) being 8.71 % (95 %CI: 6.145-11.69) and 13.17 % (95 %CI: 8.08-19.27) respectively. Among CoNS isolates, S. epidermidis was the most common with 19.3 % (95 %CI: 5.88-38.05). The prevalence of methicillin-resistant S. aureus isolates increased significantly from 23 % in 2010-2015 to 47 % in 2021-2024 (p = 0.03). S. haemolyticus is the most antibiotic-resistant species in CoNS, with 45 % of isolates resistant to methicillin, 33 % to gentamicin, and 29 % to tetracycline. Eighty-eight S. aureus strains were biofilm producers, including 35 % moderate biofilm producers and 48 % strong biofilm producers. The combined frequencies of icaA, clfA and fnbpA were 100, 99, and 89 %, respectively. The development of antibiotic resistance and biofilm formation by staphylococci involved in UTIs explains the need for periodic regional surveillance of these infections, which poses a serious public health problem.